Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Chalmers

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The British Journal of Dermatology|August 25, 2018
Towards a better understanding of outcome measurement instruments for atopic eczemaJ R Chalmers, S Danby
The British Journal of Dermatology|September 26, 2015
How to teleconference effectivelyH C Williams, J R Chalmers
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 5, 2001
Visual compatibility of amiodarone hydrochloride injection with various intravenous drugsJ R Chalmers, M B Bobek, M A Militello
Clinical and Experimental Dermatology|November 12, 2020
Scoping the international impact from four independent national dermatology trialsH C Williams, N K Rogers, J R Chalmers, et al.
The British Journal of Dermatology|January 23, 2018
How should minimally important change scores for the Patient-Oriented Eczema Measure be interpreted? A validation using varied methodsL Howells, S Ratib, J R Chalmers, et al.
The British Journal of Dermatology|March 26, 2016
Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic reviewL A A Gerbens, J R Chalmers, N K Rogers, et al.
The British Journal of Dermatology|March 31, 2015
Clearing up misunderstandings around core outcomes for atopic dermatitisH C Williams, C Apfelbacher, J R Chalmers, et al.
The British Journal of Dermatology|March 14, 2020
Assessing uptake of the Harmonising Outcome Measures for Eczema (HOME) Core Outcome Set and recommended instrumentsR Vincent, J R Chalmers, C McWilliams, et al.
The British Journal of Dermatology|February 17, 2015
A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) TrialJ R Chalmers, F Wojnarowska, G Kirtschig, et al.
BMC Medical Research Methodology|February 5, 2021
Using electronic health records to inform trial feasibility in a rare autoimmune blistering skin disease in EnglandM S M Persson, K E Harman, K S Thomas, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The British Journal of Dermatology|August 25, 2018
Towards a better understanding of outcome measurement instruments for atopic eczemaJ R Chalmers, S Danby
The British Journal of Dermatology|September 26, 2015
How to teleconference effectivelyH C Williams, J R Chalmers
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 5, 2001
Visual compatibility of amiodarone hydrochloride injection with various intravenous drugsJ R Chalmers, M B Bobek, M A Militello
Clinical and Experimental Dermatology|November 12, 2020
Scoping the international impact from four independent national dermatology trialsH C Williams, N K Rogers, J R Chalmers, et al.
The British Journal of Dermatology|January 23, 2018
How should minimally important change scores for the Patient-Oriented Eczema Measure be interpreted? A validation using varied methodsL Howells, S Ratib, J R Chalmers, et al.
The British Journal of Dermatology|March 26, 2016
Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic reviewL A A Gerbens, J R Chalmers, N K Rogers, et al.
The British Journal of Dermatology|March 31, 2015
Clearing up misunderstandings around core outcomes for atopic dermatitisH C Williams, C Apfelbacher, J R Chalmers, et al.
The British Journal of Dermatology|March 14, 2020
Assessing uptake of the Harmonising Outcome Measures for Eczema (HOME) Core Outcome Set and recommended instrumentsR Vincent, J R Chalmers, C McWilliams, et al.
The British Journal of Dermatology|February 17, 2015
A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) TrialJ R Chalmers, F Wojnarowska, G Kirtschig, et al.
BMC Medical Research Methodology|February 5, 2021
Using electronic health records to inform trial feasibility in a rare autoimmune blistering skin disease in EnglandM S M Persson, K E Harman, K S Thomas, et al.
Pageof 3